8-K - ImmunityBio, Inc. (0001326110) (Filer)
Published . Updated .
Filed: 2026-10-14 AccNo: 0001193125-26-421820 Size: 189 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- IBRX ImmunityBio
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-14 AccNo: 0001193125-26-421820 Size: 189 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 14 Oct 2026: ImmunityBio (IBRX) versus the S&P 500
Since the first closing price after “8-K - ImmunityBio, Inc. (0001326110) (Filer),” ImmunityBio (IBRX) is -15.87%. The S&P 500 fund (SPY) is -0.67% over the same days, a -15.20% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +1.78% | final price |
| GLD | the next day | +1.61% | final price |
| GLD | two days later | +0.98% | final price |
| GLD | three days later | +0.61% | still updating |
| GLD | three days earlier | +1.65% | final price |
| GLD | five days earlier | +0.71% | final price |
| ImmunityBio (IBRX) | that day | +1.21% | final price |
| ImmunityBio (IBRX) | the next day | -7.12% | final price |
| ImmunityBio (IBRX) | two days later | -15.04% | final price |
| ImmunityBio (IBRX) | three days later | -13.33% | still updating |
| ImmunityBio (IBRX) | three days earlier | +2.22% | final price |
| ImmunityBio (IBRX) | five days earlier | +0.10% | final price |
| QQQ | that day | -0.11% | final price |
| QQQ | the next day | -2.63% | final price |
| QQQ | two days later | -1.46% | final price |
| QQQ | three days later | -1.78% | still updating |
| QQQ | three days earlier | +2.33% | final price |
| QQQ | five days earlier | +2.54% | final price |
| SPY | that day | +0.28% | final price |
| SPY | the next day | -0.82% | final price |
| SPY | two days later | -0.40% | final price |
| SPY | three days later | -0.22% | still updating |
| SPY | three days earlier | +1.09% | final price |
| SPY | five days earlier | +0.55% | final price |
| TLT | that day | +1.41% | final price |
| TLT | the next day | +1.46% | final price |
| TLT | two days later | +0.74% | final price |
| TLT | three days later | +1.57% | still updating |
| TLT | three days earlier | -1.08% | final price |
| TLT | five days earlier | -1.29% | final price |
Filings that name ImmunityBio (IBRX) around 14 Oct 2026
- Lisa McClain buy ImmunityBio (IBRX) ($1,001 - $15,000). That is 14 days before publication, inside 30 days. The filing is listed beside the story “8-K - ImmunityBio, Inc. (0001326110) (Filer).”
- Lisa McClain buy ImmunityBio (IBRX) ($1,001 - $15,000). That is 16 days before publication, inside 30 days. The filing is listed beside the story “8-K - ImmunityBio, Inc. (0001326110) (Filer).”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - ImmunityBio, Inc. (0001326110) (Filer)”
Companies mentioned with this story
- IBRX ImmunityBio
ImmunityBio (IBRX) is linked, with no stored direction, high confidence in the 14 Oct 2026 story “8-K - ImmunityBio, Inc. (0001326110) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> IBRX
How “8-K - ImmunityBio, Inc. (0001326110) (Filer)” reaches ImmunityBio (IBRX)
The 14 Oct 2026 story “8-K - ImmunityBio, Inc. (0001326110) (Filer)” names ImmunityBio (IBRX) because of this story.
What ties ImmunityBio (IBRX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> IBRX
The price range for ImmunityBio (IBRX), and the dates in the story
IBRX traded between 7.76 and 10.79 across 14 sessions. The latest close on file is 8.43.
How solid “8-K - ImmunityBio, Inc. (0001326110) (Filer)” looks
44 out of 100Price not final
“8-K - ImmunityBio, Inc. (0001326110) (Filer)” scores 44 out of 100. The score uses 1 sources, a -6.30% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.